Imperial College London
Alternate

DrSarahBlagden

Faculty of Medicine, Department of Surgery & Cancer

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

s.blagden

 
 
//

Location

 

Cyclotron buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Scott:2009:10.1007/s00280-009-0968-y,
author = {Scott, EN and Thomas, AL and Molife, LR and Ahmed, S and Blagden, S and Fong, PC and Kowal, K and McCoy, C and Wiesinger, H and Steward, W and De, Bono J},
doi = {10.1007/s00280-009-0968-y},
journal = {CANCER CHEMOTHERAPY AND PHARMACOLOGY},
pages = {425--429},
title = {A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI<SUP>™</SUP>), in patients with advanced solid tumours},
url = {http://dx.doi.org/10.1007/s00280-009-0968-y},
volume = {64},
year = {2009}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Scott,EN
AU  - Thomas,AL
AU  - Molife,LR
AU  - Ahmed,S
AU  - Blagden,S
AU  - Fong,PC
AU  - Kowal,K
AU  - McCoy,C
AU  - Wiesinger,H
AU  - Steward,W
AU  - De,Bono J
DO  - 10.1007/s00280-009-0968-y
EP  - 429
PY  - 2009///
SN  - 0344-5704
SP  - 425
TI  - A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI<SUP>™</SUP>), in patients with advanced solid tumours
T2  - CANCER CHEMOTHERAPY AND PHARMACOLOGY
UR  - http://dx.doi.org/10.1007/s00280-009-0968-y
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000266495600029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 64
ER  -
Download